GreenSage Prebiotics develops and applies coconut-derived prebiotics specifically for the aquaculture industry, companion animals, and human health. The company aims to enhance health across the food chain while reducing reliance on antibiotics for growth promotion in these sectors.
Funding
$740K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The aquaculture, companion animal, and human health industries face challenges in promoting health and growth while reducing the overuse of antibiotics, which can lead to antimicrobial resistance. Reliance on antibiotics as growth promoters poses risks to the food chain and overall health.
Solution
GreenSage Prebiotics develops and applies prebiotics derived from coconuts to address these challenges. Their prebiotics are specifically formulated for use in aquaculture, companion animals, and human health applications. By incorporating these prebiotics, the company aims to improve health outcomes across the food chain. This approach reduces the need for antibiotics as growth promoters, contributing to a more sustainable and healthier ecosystem.
Target Audience
The primary customers are businesses and organizations within the aquaculture industry, the companion animal sector, and the human health market seeking alternatives to antibiotics for promoting growth and health.
Features
- Coconut-derived prebiotics for aquaculture
- Coconut-derived prebiotics for companion animals
- Coconut-derived prebiotics for human health
- Formulated to improve health outcomes
- Reduces reliance on antibiotics